These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 1109767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
    Fisher B, Rubin H, Saffer E, Wolmark N.
    Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
    Gebhardt MC, Fisher B.
    J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM, Otterstrom JR, Bartlett GL, Kreider JW.
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW.
    Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
    [Abstract] [Full Text] [Related]

  • 15. Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide.
    Fisher B, Rubin H, Wolmark N.
    J Natl Cancer Inst; 1976 Aug; 57(2):317-22. PubMed ID: 1003514
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B, Gebhardt M.
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [Abstract] [Full Text] [Related]

  • 17. Further observations on the inhibition of tumor growth by C. parvum with cyclophosphamide. VII. Effect of treatment prior to primary tumor removal on the growth of distant tumor.
    Fisher B, Gebhardt M, Saffer E.
    Cancer; 1979 Feb; 43(2):451-8. PubMed ID: 421172
    [Abstract] [Full Text] [Related]

  • 18. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV.
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [Abstract] [Full Text] [Related]

  • 19. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
    Fisher B, Linta J, Hanlon J, Saffer E.
    J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
    [No Abstract] [Full Text] [Related]

  • 20. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF, Whitehead VL, Speedy G.
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.